Source:http://linkedlifedata.com/resource/pubmed/id/18265991
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2008-4-16
|
| pubmed:abstractText |
To present an update on anti-angiogenic drugs in the treatment of metastatic renal cell carcinoma.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0724-4983
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
26
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
135-40
|
| pubmed:dateRevised |
2009-2-2
|
| pubmed:meshHeading | |
| pubmed:year |
2008
|
| pubmed:articleTitle |
Targeted therapy in renal cell carcinoma.
|
| pubmed:affiliation |
Department of Urology, Rennes University Hospital, CHU Pontchaillou, rue Henri le Guillou, 35033 Rennes, France. jean-jacques.patard@univ-rennes1.fr
|
| pubmed:publicationType |
Journal Article
|